A Study Comparing Fascia Iliaca Blockade vs Extracapsular Local Field Infiltration With Liposomal Bupivacaine

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-29

Study Completion Date

2020-03-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effectiveness of fascia iliaca blockade vs local field infiltration with liposomal bupivicaine in controlling pain, narcotic utilization and falls in the postoperative period following hip arthroscopy

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of LB in THA

NCT03341104

Hip Disease

COMPLETED

Hip Arthroscopy Pain Control Randomized Control Trial (RCT)

NCT02947178

Hip Pain Chronic Anesthesia Bupivacaine

COMPLETED PHASE4

Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy

NCT01907191

Hip Injuries

TERMINATED NA

LIA in Hip Arthroscopy Patients

NCT03070054

Pain

COMPLETED EARLY_PHASE1

Analgesic Efficacy of Fascia Iliaca Compartment Block

NCT03957499

Analgesia

UNKNOWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose the research is to help determine optimal means of post-operative analgesia following hip arthroscopic procedures. Post-operative pain is a significant contributor to patient satisfaction and the side effects of narcotic pain medication are well described. The ideal intervention for achieving appropriate analgesia following hip arthroscopy has not yet been defined. Determining means of achieving acceptable post-operative pain relief while minimizing narcotic usage will help yield maximal patient outcomes.The primary research procedures entailed in this study include fascia iliaca nerve blockade with Marcaine and local field infiltration with liposomal bupivicane (Exparel). The patients in this study will include those who have both a clinical and radiographic diagnosis of femoracetabular impingement (FAI), have failed non operative treatment, and are indicated for hip arthroscopy with labral repair and femoroplasty/acetabuloplasty. The study includes the surgical procedure and the first post-operative follow up visit. The total study duration is approximately 1.5 weeks for each patient. The study will be carried out until the patients first post-operative visit which typically occurs 7-10 days after the procedure. We are to include approximately 40 patients in total for this study over a period of 4 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoro Acetabular Impingement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liposomal Bupivicaine

Following hip arthroscopy, local field infiltration with liposomal bupivicaine will be performed for adjunct pain control

Group Type ACTIVE_COMPARATOR

liposomal bupivicaine

Intervention Type DRUG

local field infiltration

fascia iliaca blockade

Preoperatively before hip arthroscopy, a fascia iliaca blockade will be performed for adjunct pain control

Group Type ACTIVE_COMPARATOR

Fascia iliaca blockade

Intervention Type PROCEDURE

fascia iliaca compartment blockade

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

liposomal bupivicaine

local field infiltration

Intervention Type DRUG

Fascia iliaca blockade

fascia iliaca compartment blockade

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

exparel

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients (\>18 years old)
* diagnosed FAI that are indicated for hip arthroscopic labral repair and femoroplasty/acetabuloplasty.

Exclusion Criteria

* patients undergoing revision procedures, bilateral procedures,
* advanced osteoarthritis (\<2mm joint space on plain radiographs)
* frank dysplasia (anterior and/or lateral center edge angles \<20 degrees and/or Tonnis angle \>15 degrees)
* diagnoses other than FAI (Legg Calve Perthes, femoral head avascular necrosis, septic arthritis, or post traumatic deformity).
* allergy to liposomal bupivicaine

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No